OncoTrack Consortium Launches $35.6M Colon Cancer Initiative
March 11, 2011
OncoTrack Consortium Launches $35.6M Colon Cancer Initiative
OncoTrack, a new international consortium, will seek to generate high-quality genomic and epigenetic data from clinically well-defined colon cancer tumors and their metastases as part of its colon cancer project.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- NCATS Launches Drug Repurposing Project with Big Pharma, Investigators
May 3, 2012 / GenomeWeb Daily News - Diaceutics Report Sheds Doubt on Pharmas' Personalized Medicine Preparedness
June 15, 2011 / Pharmacogenomics Reporter - PGx Drugs Xalkori, Zelboraf Show Strong Growth in First Quarter of 2013
May 1, 2013 / Pharmacogenomics Reporter - France Funds $17M Cancer Profiling, Biomarker Effort
March 13, 2013 / GenomeWeb Daily News - Vanderbilt Evaluating GE Platform for Insights into Colon Cancer
February 12, 2013 / GenomeWeb Daily News